Logo

Third Wave Stock Price Drops 7.8 Percent On News of Stratagene Suit

May 12, 2005

NEW YORK, May 12 (GenomeWeb News) - The share price of Third Wave Technologies has fallen 7.8 percent, or $.31, as investors reacted warily to the news that the company is being sued by Stratagene for alleged infringement of two of that company's copyrights.

 

Stratagene said Third Wave's Invader technology infringed on two of the four patents behind its FullVelocity line of Q-PCR products mid-day on May 9. Third Wave's stock price stood at $4.26 when the market closed May 9, and has dropped to $3.95 in mid-after noon trading today.

 

Third Wave sued Stratagene in September, claiming that FullVelocity patents infringed on its Invader patents. That suit is ongoing.

Breaking News
The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.